Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company
MWN-AI** Summary
Livechain, Inc. (OTCX: LICH), a subsidiary of Vyome Holdings, Inc. (Nasdaq: HIND), has announced the acquisition of senior secured debt from Humanyze, an AI-enabled HR analytics company that originated from the MIT Media Lab. The transaction, structured as an all-stock deal valued at approximately $325,000, involved Livechain issuing common stock in exchange for a convertible note held by Remus Capital, which financed Humanyze. This acquisition marks Livechain's strategic entry into the burgeoning AI-driven HR market, positioning the company for potential uplisting to a national exchange by 2026.
As part of the agreement, Livechain will take over Humanyze's assets, including intellectual property and daily operational control. The acquisition addresses critical challenges faced by large enterprises in managing human capital, particularly in an era increasingly influenced by AI. Humanyze's platform leverages data analytics to provide actionable insights aimed at optimizing employee development and retention effectively.
Krishna Gupta, Chairman of Vyome, stated that this transformative transaction could create significant shareholder value not just for Livechain but also for Vyome as its majority shareholder. Venkat Nelabhotla, Vyome’s CEO, emphasized that the company would maintain operational independence from Vyome, ensuring that Livechain could adequately execute its growth plans and capitalize on the AI HR landscape without relying on Vyome's resources.
In summary, Livechain's acquisition of Humanyze represents a pivotal move to enhance its capabilities in AI-driven workforce analytics. The strategic focus is on harnessing technology to address workforce efficiencies, and the successful execution of this plan could lead to a significant upswing in shareholder value and establish Livechain's presence in the competitive AI sector.
MWN-AI** Analysis
Livechain, Inc. (OTCX: LICH), through its acquisition of Humanyze's secured debt, is making significant strides into the AI-driven HR analytics arena, a sector poised for explosive growth. This maneuver not only positions Livechain as a formidable player but also sets a timeframe for potential uplisting to a national exchange by 2026—a testament to its growth ambitions. Following a strategic partnership with Remus Capital, a leading venture capital firm, Livechain has effectively integrated valuable intellectual property and operational control over Humanyze, a company leveraging MIT-backed analytics to optimize workforce management and human capital allocation.
Investors should perceive this acquisition as a transformative opportunity that enhances Livechain's asset base while paving the way for superior shareholder returns. The human capital management landscape is increasingly relying on AI and data analytics, making the services offered by Humanyze critically relevant. As Fortune 1000 firms confront elevated costs in talent management, the actionable insights facilitated by an AI-enabled platform can significantly enhance organizational efficiency and employee satisfaction.
Furthermore, Livechain is adamant about maintaining operational independence from its parent company, Vyome Holdings, which reduces the risk of operational entanglements affecting overall performance. The ambitious outlook articulated by Livechain's leadership suggests a confidence in scaling operations and value creation.
For current shareholders and potential investors, this sets up a compelling narrative. Market participants looking for exposure to innovative tech in human resources should consider accumulating shares, especially as Livechain approaches potential uplisting criteria. However, it is also crucial to remain cautious, as the forward-looking nature of this acquisition comes with inherent market risks and uncertainties that could impact performance. Ultimately, while the fundamentals are strong, investors should closely monitor execution and market conditions in the evolving AI landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Livechain Creates Path to Seek Potential Uplisting to National Exchange in 2026
Livechain, Inc. (“Livechain”) (OTCX: LICH) , a subsidiary of Vyome Holdings, Inc. (“Vyome”) (Nasdaq: HIND), announced today that it has executed a debt purchase agreement with Remus Capital, a leading AI-focused venture capital firm, in order to acquire Sociometric Solutions, Inc, d/b/a, Humanyze (“Humanyze”), a rapidly emerging human resources data and analytics company.
The transaction was structured as an all-stock transaction in which LICH issued shares of its common stock, valued at approximately $325,000, in exchange for acquiring a senior, secured convertible note issued to Remus by Humanyze. Through this transaction, LICH has initiated a default and asset transfer in order to assume all business assets, including intellectual property and trade secrets, and to take direct control of the daily operations of Humanyze.
Born from the prestigious MIT Media Lab, Humanyze is working to redefine the future of work through science-backed analytics and AI-enabled, data-driven insights that help large, complex companies make continuous workplace improvements that benefit both employees and the businesses.
“First of all, this transaction transforms Livechain, driving it into an exciting and rapidly evolving AI HR space, creating a path for uplisting to a national exchange, and giving it the potential to generate real value for its shareholders. Second, the value creation under Livechain also has the potential to deliver real and lasting value to the shareholders of Vyome. As the majority shareholder of Livechain, Vyome stands to benefit significantly from any value created under Livechain. Our focus is on shareholder value, and our desire is that as Livechain’s underlying value increases, Vyome will be positioned to increase its Livechain equity position,” said Krishna Gupta, Chairman of Vyome.
“Humanyze is attacking one of the biggest issues facing Fortune 1000 companies around the world – human capital, and the cost of developing, retaining, and rewarding people in the most cost-effective way possible, all of which is even more important in an AI-first world. We see multiple ways for Humanyze to create value and position Livechain for an uplisting to a national exchange. Livechain will have its own team and plans to have its own capital on a go-forward basis. We do not anticipate that Livechain will be using any capital or operational bandwidth of Vyome,” said Venkat Nelabhotla, CEO of Vyome and board member of Livechain.
Humanyze has built a compelling AI-enabled platform that breaks down critical employment-driven data to give employers clear, actionable data that contributes not only to the tangible bottom line but also to the optimization of many companies’ most valuable resources, their human capital.
About Livechain, Inc.
Livechain is currently focused on pursuing strategic alternatives in emerging technology sectors. Livechain intends to enter the artificial intelligence space through the planned acquisition of AI-driven assets focused on human capital, workforce intelligence, and human relationship management. Additionally, Livechain seeks to evaluate additional synergistic opportunities in order to build a scalable AI platform related to its pursuits.
Livechain Forward-Looking Statement Disclosure
This press release contains statements that do not relate to historical facts but are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can generally (although not always) be identified by their use of terms and phrases such as anticipate, appear, believe, continue, could, estimate, expect, indicate, intend, may, plan, possible, predict, project, pursue, will, would and other similar terms and phrases, as well as the use of the future tense. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations, and assumptions regarding the future of the business of the Livechain, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements in this press release speak only as of the date hereof. Unless otherwise required by law, we undertake no obligation to publicly update or revise these forward-looking statements, whether because of new information, future events, or otherwise.
About Vyome Holdings, Inc.
Vyome is building the world’s premier platform spanning the US-India innovation corridor. Based in Cambridge, MA, Vyome’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning across the US-India innovation corridor, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety. To learn more, please visit www.vyometx.com .
Vyome Forward-Looking Statements
Certain statements made in this press release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “target,” “believe,” “expect,” “will,” “shall,” “may,” “anticipate,” “estimate,” “would,” “positioned,” “future,” “forecast,” “intend,” “plan,” “project,” “outlook,” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such statements include, but are not limited to, statements contained in this press release relating to Vyome’s business strategy, Vyome’s future operating results, and liquidity and capital resources outlook. Forward-looking statements are based on Vyome’s current expectations and assumptions regarding Vyome’s business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Vyome’s actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. Vyome cautions you, therefore, against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, Vyome’s ability to raise capital to fund continuing operations; its ability to protect Vyome’s intellectual property rights; the impact of any infringement actions or other litigation brought against Vyome; competition from other providers and products; Vyome’s ability to develop and commercialize products and services; changes in government regulation; Vyome’s ability to complete capital raising transactions; and other factors relating to Vyome’s industry, operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause Vyome’s actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. Vyome assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release, except as may be required under applicable securities law.
Visit us on social media:
View source version on businesswire.com: https://www.businesswire.com/news/home/20260224353193/en/
Media and Investor Relations Contact
contact@vyometx.com
FAQ**
What specific strategies does Livechain Inc LICH plan to implement to ensure a successful uplisting to a national exchange by 2026?
How does the acquisition of Humanyze enhance Livechain Inc LICH's competitive advantage in the AI HR space?
What are the anticipated financial impacts on Livechain Inc LICH's operations following the integration of Humanyze's assets and technology?
Can Livechain Inc LICH provide more details on its plans for capital generation and operational independence from Vyome Holdings post-acquisition?
**MWN-AI FAQ is based on asking OpenAI questions about Vyome Holdings Inc. (NASDAQ: HIND).
NASDAQ: HIND
HIND Trading
1.75% G/L:
$2.62 Last:
14,458 Volume:
$2.68 Open:



